Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001493152-25-006632
Filing Date
2025-02-14
Accepted
2025-02-14 09:59:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 10289
  Complete submission text file 0001493152-25-006632.txt   11972
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Subject) CIK: 0001635088 (see all company filings)

EIN.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-93291 | Film No.: 25624261
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 69 GROSVENOR STREET LONDON X0 W1K 3JP
Business Address 69 GROSVENOR STREET LONDON X0 W1K 3JP 650-562-8211
SB INVESTMENT ADVISERS (UK) LTD (Filed by) CIK: 0001731509 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0331
Type: SCHEDULE 13G/A